Skip to main content

Find Clinical Trials

Home
Conditions
Diabetes Mellitus, Type 2

Clinical trial condition

Diabetes Mellitus, Type 2

Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.

7,977 public trials 716 recruiting studies

Refine in advanced search Browse all conditions

Diabetes Mellitus, Type 2 trial results

Completed

Body Weight Effects on Glucophage's Efficacy in Chinese Diagnosed T2DM Patients

NCT00778622

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations: Local Institution Beijing, Beijing Municipality, China

Local Institution Beijing, Beijing Municipality, China

Local Institution Beijing, Beijing Municipality, China

Local Institution Beijing, Beijing Municipality, China

View all 14 locations

View Trial Details

Completed

A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of KRP-104 in Patients With Type 2 Diabetes Inadequately Controlled on Metformin Alone

NCT00525330

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations: San Diego, California, United States

View Trial Details

Completed

Endothelial Function in Hispanic Children/Adolescents at Risk for Type 2 Diabetes

NCT01926925

Conditions: Body Weight, Diabetes Mellitus, Diabetes Mellitus, Type 2, +12 more
Locations: Not specified

View Trial Details

Completed

Effect of Different Interventions on Glycemic Control and β-cell Function in Newly Diagnosed Type 2 Diabetic Patients

NCT01147627

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations: China-Japan Friendship Hospital Beijing, Beijing Municipality, China

Peking University People's Hospital Beijing, Beijing Municipality, China

Beijing Hospital Beijing, Beijing Municipality, China

Chinese PLA General Hospital Beijing, Beijing Municipality, China

View all 25 locations

View Trial Details

Completed

Avoiding Diabetes After Pregnancy Trial

NCT01923350

Conditions: Body Weight, Body Weight Changes, Diabetes Mellitus, +13 more
Locations: Social & Scientific Systems Inc. Silver Spring, Maryland, United States

View Trial Details

Completed

Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Type 2 Diabetes Mellitus

NCT01663220

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +7 more
Locations: ICON Development Solutions, Gault Lane San Antonio, Texas, United States

View Trial Details

Completed

An Efficacy, Safety, and Tolerability Study of Canagliflozin in Patients With Type 2 Diabetes Mellitus Who Have Moderate Renal Impairment

NCT01064414

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +10 more
Locations: Concord, California, United States

Fountain Valley, California, United States

San Diego, California, United States

Denver, Colorado, United States

View all 106 locations

View Trial Details

Completed

Effects of 5-day Statin Withdrawal on Endothelial Progenitor Cells and Inflammatory Markers in Type 2 Diabetic Patients

NCT01600690

Conditions: Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +15 more
Locations: University Hospital Diabetes Outpatient Clinic Padova, Italy

View Trial Details

Completed

Patient Preference and Satisfaction With Insulin Glargine (Lantus) Solostar Pen vs Conventional Vial-Syringe Method of Lantus Injection Therapy in Patients With Type 2 Diabetes Mellitus

NCT01226043

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations: Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States

View Trial Details

Completed

Study Of Safety And Efficacy Of PF-04991532 In Subjects With Type 2 Diabetes Mellitus

NCT01336738

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Diabetes, Type 2, +4 more
Locations: Pfizer Investigational Site Jonesboro, Arkansas, United States

Pfizer Investigational Site Jonesboro, Arkansas, United States

Pfizer Investigational Site Los Angeles, California, United States

Pfizer Investigational Site Palm Springs, California, United States

View all 44 locations

View Trial Details